EcoDrugPlus

Atpase Na+/k+ Transporting Subunit Beta 2

Ensembl ID : ENSCHYG00000011403
Gene Symbol: ATP1B2
1 Cross references
269 Possible Orthologues:

Atr Serine/threonine Kinase

Ensembl ID : ENSCHYG00000022692
Gene Symbol: ATR
1 Cross references
207 Possible Orthologues:

Axl Receptor Tyrosine Kinase

Ensembl ID : ENSCHYG00000027177
Gene Symbol: AXL
1 Cross references
198 Possible Orthologues:

B-Raf Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSCHYG00000020466
Gene Symbol: BRAF
1 Cross references
220 Possible Orthologues:

Bcl2 Apoptosis Regulator

Ensembl ID : ENSCHYG00000015003
Gene Symbol: BCL2
1 Cross references
228 Possible Orthologues:

Bcl2 Related Protein A1

Ensembl ID : ENSCHYG00000006849
Gene Symbol: BCL2A1
1 Cross references
133 Possible Orthologues:

Bcr Activator Of Rhogef And Gtpase

Ensembl ID : ENSCHYG00000012663
Gene Symbol: BCR
1 Cross references
286 Possible Orthologues:

Bruton Tyrosine Kinase

Ensembl ID : ENSCHYG00000016353
Gene Symbol: BTK
1 Cross references
207 Possible Orthologues:

C-C Motif Chemokine Receptor 2

Ensembl ID : ENSCHYG00000022950
Gene Symbol: CCR2
1 Cross references
150 Possible Orthologues:

C-C Motif Chemokine Receptor 4

Ensembl ID : ENSCHYG00000026954
Gene Symbol: CCR4
1 Cross references
113 Possible Orthologues:

C-C Motif Chemokine Receptor 5

Ensembl ID : ENSCHYG00000022968
Gene Symbol: CCR5
1 Cross references
152 Possible Orthologues:

C-C Motif Chemokine Receptor 9

Ensembl ID : ENSCHYG00000022506
Gene Symbol: CCR9
1 Cross references
265 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).